NBDC Research ID: hum0018.v2

 

SUMMARY

Aims: Identify causative genes or susceptible genes in neurodegenerative diseases

Methods: Whole exome sequencing, whole genome sequencing and RNA sequencing analyses using Illumina HiSeq 2000/2500

Participants/Materials:

14 patients with multiple system atrophy and 7 healthy control subjects

69 patients with Charcot-Marie-Tooth disease (CMT)

21 patients with Frontotemporal dementia (FTD)

121 patients with Familial amyotrophic lateral sclerosis (Familial ALS)

85 patients with Myopathy

490 patients with Sporadic amyotrophic lateral sclerosis (Sporadic ALS)

9 patients with Motor neuron disease (MND)

465 patients with Spastic paraplegia

 

Dataset IDType of DataCriteriaRelease Date
JGAS000009 NGS (Exome) Controlled-access (Type I) 2015/02/03
JGAS000337 NGS (Exome) Controlled-access (Type I) 2025/07/16
JGAS000374 NGS (Exome) Controlled-access (Type I) 2025/07/16
JGAS000358 NGS (WGS, Exome, RNA-seq) Controlled-access (Type I) 2025/07/16
JGAS000365 NGS (WGS, Exome) Controlled-access (Type I) 2025/07/16
JGAS000393 NGS (WGS, Exome, RNA-seq) Controlled-access (Type I) 2025/07/16
JGAS000422 NGS (Exome) Controlled-access (Type I) 2025/07/16
JGAS000494 NGS (WGS, Exome) Controlled-access (Type I) 2025/07/16

*Release Note

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

Exome

Participants/Materials

[JGAS000009] multiple system atrophy (ICD10: G70.9) 14 cases and 7 healthy control subjects

[JGAS000337] CMT (ICD10: G60.0): 69 cases 72 samples

[JGAS000374] FTD (ICD10: G31.0): 21 cases 22 samples

[JGAS000358] Familial ALS (ICD10: G12.2): 119 cases 125 samples

[JGAS000365] Myopathy (IC510: G72.9): 82 cases 85 samples

[JGAS000393] Sporadic ALS (ICD10:G82.1): 482 cases 484 samples

[JGAS000422] MND (ICD10: G122): 9 cases 9 samples

[JGAS000494] Spastic paraplegia (ICD10: G82.1): 464 cases 469 samples

Targets Exome
Target Loci for Capture Methods

-

Platform Illumina [HiSeq 2000/2500]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name)

SureSelect Human All Exon 50 Mb Kit

SureSelect Human All Exon V4 Kit

SureSelect Human All Exon V5 Kit

SureSelect Human All Exon V6 Kit

SureSelect Human All Exon V7 Kit

Fragmentation Methods Ultrasonic fragmentation (Covaris S220)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Japanese Genotype-phenotype Archive Dataset ID

JGAD000009: multiple system atrophy and healthy control subjects

JGAD000448: CMT

JGAD000488: FTD

JGAD000472: Familial ALS

JGAD000479: Myopathy

JGAD000510: Sporadic ALS

JGAD000539: MND

JGAD000611: Spastic paraplegia

Total Data Volume

JGAD000009: 260 GB (fastq)

JGAD000448: 9.7 GB (fastq)

JGAD000488: 27.7 GB (fastq)

JGAD000472: 17.2 TB (fastq)

JGAD000479: 22.1 TB (fastq)

JGAD000510: 33.2 TB (fastq)

JGAD000539: 55.6 GB (fastq)

JGAD000611: 116.5 TB (fastq)

Comments (Policies) NBDC policy

 

WGS

Participants/Materials

[JGAS000358] Familial ALS (ICD10: G12.2): 1 case 1 sample

[JGAS000365] Myopathy (ICD10: G72.9): 3 cases 3 samples

[JGAS000393] Sporadic ALS (ICD10: G122): 1 case 1 sample (brain tissues)

[JGAS000494] Spastic paraplegia (ICD10: G82.1): 2 cases 2 samples (blood)

Targets WGS
Target Loci for Capture Methods

-

Platform Illumina [HiSeq 2500]
Library Source gDNA extracted from peripheral blood cells or brain tissues
Cell Lines -
Library Construction (kit name) TruSeq DNA PCR-Free Sample Prep Kit
Fragmentation Methods Ultrasonic fragmentation (Covaris S220)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 150 bp
Japanese Genotype-phenotype Archive Dataset ID

JGAD000472: Familial ALS

JGAD000479: Myopathy

JGAD000510: Sporadic ALS

JGAD000611: Spastic paraplegia

Total Data Volume

JGAD000472: 17.2 TB (fastq)

JGAD000479: 22.1 TB (fastq)

JGAD000510: 33.2 TB (fastq)

JGAD000611: 116.5 TB (fastq)

Comments (Policies) NBDC policy

 

 

RNA-seq

Participants/Materials

[JGAS000358] Familial ALS (ICD10: G12.2): 1 case 1 sample (cerebellum tissue)

[JGAS000393] Sporadic ALS (ICD10: G122): 8 cases 22 samples (brain tissues)

Targets RNA-seq
Target Loci for Capture Methods

-

Platform Illumina [HiSeq 2500]
Library Source RNA extracted from brain tissues
Cell Lines -
Library Construction (kit name) TruSeq RNA Library Prep Kit v2
Fragmentation Methods Heat treatment (TruSeq RNA Library Prep Kit v2)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 101 bp
Japanese Genotype-phenotype Archive Dataset ID

JGAD000472: Familial ALS

JGAD000510: Sporadic ALS

Total Data Volume JGAD000472: 17.2 TB (fastq)

JGAD000510: 33.2 TB (fastq)

Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Shoji Tsuji

Affiliation: Department of Neurology, Graduate School of Medicine, The University of Tokyo

Project / Group Name:

Funds / Grants (Research Project Number):

NameTitleProject Number
Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT) KAKENHI Genome Science 211S0002
Practical Research Project for Rare/Intractable Diseases, Japan Agency for Medical Research and Development (AMED) Elucidation of the Etiology and Pathogenesis of Adult-Onset Neurodegenerative Diseases Based on Whole Genome Analysis JP20ek0109491
Practical Research Project for Rare/Intractable Diseases, Japan Agency for Medical Research and Development (AMED) Elucidation of the Pathogenesis of Rare and Intractable Neurological Diseases Based on Omics Analysis JP17ek0109279
Program for an Integrated Database of Clinical and Genomic Information, Japan Agency for Medical Research and Development (AMED) Development of Clinical Genomic Information Integrated Database for Rare and Intractable Diseases JP16kk0205001
Practical Research Project for Rare/Intractable Diseases, Japan Agency for Medical Research and Development (AMED) Comprehensive Genetic Analysis Study for Neurological Diseases of Unknown Cause JP14ek0109065

 

PUBLICATIONS

TitleDOIDataset ID
1 Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. doi:10.1056/NEJMoa1212115 JGAD000009
2 Loss-of-function variants in NEK1 are associated with an increased risk of sporadic ALS in the Japanese population doi:10.1038/s10038-020-00830-9 JGAD000472
JGAD000510
3 Juvenile amyotrophic lateral sclerosis with complex phenotypes associated with novel SYNE1 mutations doi:110.1080/21678421.2020.1813312 JGAD000472
4 Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis doi:10.1007/s10048-020-00626-1 JGAD000472
5 Atypical Familial Amyotrophic Lateral Sclerosis with Slowly Progressing Lower Extremities-predominant Late-onset Muscular Weakness and Atrophy doi:10.2169/internalmedicine.2222-18 JGAD000472
JGAD000539
6 Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations doi:10.1007/s10048-019-00570-9 JGAD000472
JGAD000510
7 Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS doi:10.1136/jnnp-2018-318568 JGAD000472
JGAD000510
8 Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis doi:10.1016/j.neurobiolaging.2017.12.005 JGAD000472
JGAD000510
9 Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation doi:10.1016/j.neurobiolaging.2017.08.030 JGAD000472
10 ERBB4 Mutations that Disrupt the Neuregulin-ErbB4 Pathway Cause Amyotrophic Lateral Sclerosis Type 19 doi:10.1016/j.ajhg.2013.09.008 JGAD000472
11 Mutational analysis of familial and sporadic amyotrophic lateral sclerosis with OPTN mutations in Japanese population doi:10.3109/17482968.2012.684213 JGAD000472
JGAD000510
12 C9ORF72 Repeat Expansion in Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan doi:10.1001/archneurol.2012.1219 JGAD000472
13 A mutation database for amyotrophic lateral sclerosis doi:10.1002/humu.21306 JGAD000472
14 Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease doi:10.1038/s41588-019-0458-z JGAD000479
15 Tubular aggregate myopathy caused by a novel mutation in the cytoplasmic domain of STIM1 doi:10.1212/NXG.0000000000000050 JGAD000479
16 Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation doi:10.1111/nan.12179 JGAD000479
17 Chédiak-Higashi syndrome presenting as a hereditary spastic paraplegia doi:10.1038/s10038-021-00977-z JGAD000611
18 Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia doi:10.1093/brain/awab041 JGAD000611
19 SPG9A with the new occurrence of an ALDH18A1 mutation in a CMT1A family with PMP22 duplication: case report doi:10.1186/s12883-021-02087-x JGAD000611
20 Identification of a novel mutation in ATP13A2 associated with a complicated form of hereditary spastic paraplegia doi:10.1212/NXG.0000000000000514 JGAD000611
21 A novel mutation in the GBA2 gene in a Japanese patient with SPG46: A case report doi:10.1016/j.ensci.2020.100238 JGAD000611
22 Clinical features of inherited neuropathy with BSCL2 mutations in Japan doi:10.1111/jns.12369 JGAD000611
23 VPS13D-related disorders presenting as a pure and complicated form of hereditary spastic paraplegia doi:10.1002/mgg3.1108 JGAD000611
24 A Novel de novo KIF1A Mutation in a Patient with Autism, Hyperactivity, Epilepsy, Sensory Disturbance, and Spastic Paraplegia doi:10.2169/internalmedicine.3661-19 JGAD000611
25 UBAP1 mutations cause juvenile-onset hereditary spastic paraplegias (SPG80) and impair UBAP1 targeting to endosomes doi:10.1038/s10038-019-0670-9 JGAD000611
26 Spastic Paraplegia Accompanied by Extrapyramidal Sign and Frontal Cognitive Dysfunction doi:10.2169/internalmedicine.2765-19 JGAD000611
27 The novel de novo mutation of KIF1A gene as the cause for Spastic paraplegia 30 in a Japanese case doi:10.1016/j.ensci.2018.11.026 JGAD000611
28 A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy doi:10.1038/s10038-018-0538-4 JGAD000611
29 PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia doi:10.1038/s10038-018-0519-7 JGAD000611
30 Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment doi:10.1038/s10038-018-0477-0 JGAD000611
31 Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses doi:10.1038/jhg.2015.159 JGAD000611
32 Exome sequencing reveals a novel missense mutation in the KIAA0196 gene in a Japanese patient with SPG8 doi:10.1016/j.clineuro.2016.02.031 JGAD000611
33 Novel mutations in the PNPLA6 gene in Boucher-Neuhäuser syndrome doi:10.1038/jhg.2015.3 JGAD000611
34 Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation doi:10.1038/srep07132 JGAD000611
35 Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation doi:10.1136/jnnp-2013-306981 JGAD000611
36 Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses doi:10.1038/jhg.2013.139 JGAD000611
37 Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12 doi:10.1002/humu.22378 JGAD000611
38 A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55) doi:10.1136/jmedgenet-2012-101212 JGAD000611

 

 

USERS (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use
Satoshi Yuhara Bioinformatics section, SRL inc. Japan Validation of Rare Disease Clinical Reporting System JGAD000009 2024/07/01-2027/03/31